Kidney Stone Management Market Analysis

Kidney Stone Management Market Analysis

To get key market trends

  Download Free Sample

The calcium oxalate segment was valued at USD 1,767.2 million in 2022 and is expected to grow at 5.5% CAGR by 2032. The kidney stones management market pre-dominantly consists of calcium oxalate.

• More than 75% of kidney stones are composed of calcium oxalate and calcium phosphate followed by struvite, uric acid and cysteine.
  
   
• Various risk factors that lead to calcium oxalate stone formation include diet that contains high levels of protein, oxalate, sodium or sugar.  Other factors include obesity, various medical conditions and digestive disorders. Rising prevalence of obesity among population has led to an increased incidence of kidney stones, thereby, stimulating market growth.

   

Based on diagnostics, the kidney stone management market is categorised into abdominal x-ray, computed tomography, ultrasound, abdominal MRI, intravenous pyelography, and others. The ultrasound segment held a notable market share and is anticipated to reach USD 1,075.2 million by 2032. Ultrasound is widely used imaging modality for kidney stones diagnosis.

• This noninvasive procedure involves use of sound waves without need for radiation exposure and contrast dye. Hence, this technique is popular in pregnant women and patients who are allergic to contrast dye.

   

• As ultrasound does not employ ionizing radiation, American College of Radiology, American Urological Association, and European Association of Urology recommend it to be first-line diagnostic technology for young and pregnant patients.

   

• In addition, this technology can be used with increased accuracy in children due to their small body size. Ultrasound has good diagnostic ability as compared to CT scan for detection and sizing of small stones. As a result, the above-mentioned factors will stimulate market expansion.

   

The kidney stone management market from extracorporeal shock wave lithotripsy (ESWL) segment held a dominant market share in 2022 and is anticipated to reach USD 2,357 million by 2032. The dominant market share is attributed to convenience and non-invasive nature of shock waves procedure for treating kidney stones. These devices deliver shock waves externally through the skin, avoiding the need for invasive procedures.

• ESWL is generally less painful and comfortable for patients compared to surgical procedures. Anesthesia is often not required, and most patients can return to their regular activities shortly after treatment.

   

• Moreover, the ESWL devices are now being developed with new sources for generating shock waves, such as electromagnetic and piezoelectric sources. Additionally, these devices have been reduced in size occupying less space with more efficient targeting systems to deliver accurate energy to stones. As a result, the above-mentioned factors will stimulate market progress.
   

The U.S. dominated the North America kidney stones management market in 2022 and is anticipated to expand at a considerable pace to reach around USD 1.5 billion by 2032. The dominant market share is attributed to the increasing prevalence and recurrence rate of kidney stone disease in the country.

• U.S. witnesses high screening and diagnosis rate due to increased awareness regarding disease. Moreover, the presence of prominent players such as Boston Scientific Corporation, Becton, Dickinson and Company, and Olympus Corporation among others are engaged in the new product development & commercialization that facilitates the industrial expansion in the country.

   

• Additionally, better access to advanced treatment options such as ureteroscopy and minimally invasive surgeries, have made procedures safer, less invasive, and more effective. These advancements have attracted individuals who may have been hesitant about surgical options in the past. Thus, the above-mentioned variables would augment the business growth in the U.S.